These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19898508)

  • 1. Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD?
    Merlin E; Paillard C; Rochette E; David A; Isfan F; Doré E; Deméocq F; Kanold J
    Bone Marrow Transplant; 2010 May; 45(5):963-5. PubMed ID: 19898508
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
    Perotti C; Del Fante C; Viarengo G; Salvaneschi L
    Transfusion; 2004 Oct; 44(10):1531-2. PubMed ID: 15383028
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
    Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis in children with graft-versus-host disease.
    Chan KW
    J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment.
    Kanold J; Messina C; Halle P; Locatelli F; Lanino E; Cesaro S; Deméocq F;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S69-71. PubMed ID: 15812535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
    Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
    Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients.
    Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.
    Jagasia M; Greinix H; Robin M; Das-Gupta E; Jacobs R; Savani BN; Engelhardt BG; Kassim A; Worel N; Knobler R; Russell N; Socie G
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1129-33. PubMed ID: 23623892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
    Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy.
    Perutelli P; Rivabella L; Lanino E; Pistoia V; Dini G
    Haematologica; 2002 Mar; 87(3):335-6. PubMed ID: 11869954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
    Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
    Bone Marrow Transplant; 2002 Dec; 30(11):761-8. PubMed ID: 12439699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.